The Valley Desk

NCT00709618 · Interventional trial

Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects

Overall registry status Terminated

Phase 2

Conditions Neoplasms, Breast

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov